Abstract
E. Kerem1, M. Wilschanski1, I. Sermet-Gaudelus2, K. De Boeck3, F.J. Accurso4, M. Konstan5, S. Rowe6, N. Miller7, G. Elfring7, R. Spiegel7, S. Peltz7, J. Barth7, T. Ajayi7, Ataluren CF Study Group. 1Hadassah University Hospital, Jerusalem, Israel; 2Hopital Necker, Paris, France; 3University Hospital Leuven, Leuven, Belgium; 4Children’s Hospital Colorado, Aurora, United States; 5Rainbow Babies and Children’s Hospital, Cleveland, United States; 6University of Alabama-Birmingham, Birmingham, United States; 7PTC Therapeutics, Inc, South Plainfield, United States
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
